# OpenAI is rolling out an early version of an artificial intelligence model meant to speed up drug discoveries.

*genai · news · 2026-04-16 · Moneycontrol*

## Key points

- OpenAI has launched GPT-Rosalind, an AI model specifically for life sciences research.
- GPT-Rosalind will be initially available to select business customers like Amgen, Moderna, and the Allen Institute.
- Shares of existing drug discovery companies fell sharply following OpenAI's model announcement.
- OpenAI's GPT-Rosalind includes high-precision security flags to detect potential bioweapon-related use.

**Companies:** OpenAI, Alphabet Inc., Amgen Inc., Moderna Inc., IQVIA Holdings Inc., Charles River Laboratories International Inc., Recursion Pharmaceuticals Inc., Schrodinger Inc.
**Countries:** United States

[Read the full story on Moneycontrol](https://www.moneycontrol.com/artificial-intelligence/openai-takes-on-google-with-new-ai-model-aimed-at-drug-discovery-article-13891355.html)

---

Canonical: https://newsio.io/n/76eb1d03-2baa-4af2-a1ac-f8d0596a94a1/openai-is-rolling-out-an-early-version-of-an-artificial-intelligence-model-meant
Summarized by Newsio from Moneycontrol. https://newsio.io/how-it-works